WO2006061373A2 - Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites - Google Patents
Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites Download PDFInfo
- Publication number
- WO2006061373A2 WO2006061373A2 PCT/EP2005/056501 EP2005056501W WO2006061373A2 WO 2006061373 A2 WO2006061373 A2 WO 2006061373A2 EP 2005056501 W EP2005056501 W EP 2005056501W WO 2006061373 A2 WO2006061373 A2 WO 2006061373A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen
- compound
- alkyl
- tetrahydropyridin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0518465-7A BRPI0518465A2 (en) | 2004-12-07 | 2005-12-06 | compound, method for the preparation of compound, pharmaceutical composition, method of preparing a composition, and use of a compound |
CA002587936A CA2587936A1 (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
AU2005313387A AU2005313387A1 (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
MX2007006757A MX2007006757A (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites. |
EP05817509A EP1828168A2 (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
JP2007544893A JP2008523027A (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-ylindoles with a combination of affinity for the dopamine-D2 receptor and a serotonin resorption site |
IL183202A IL183202A0 (en) | 2004-12-07 | 2007-05-15 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites |
NO20073389A NO20073389L (en) | 2004-12-07 | 2007-07-02 | Tetrahydropyridin-4-ylndoles with a combination of affinity for dopamine D2 receptors and serotonin reuptake sites |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63343904P | 2004-12-07 | 2004-12-07 | |
EP04106351 | 2004-12-07 | ||
US60/633,439 | 2004-12-07 | ||
EP04106351.2 | 2004-12-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006061373A2 true WO2006061373A2 (en) | 2006-06-15 |
WO2006061373A3 WO2006061373A3 (en) | 2006-09-21 |
Family
ID=34930005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/056501 WO2006061373A2 (en) | 2004-12-07 | 2005-12-06 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1828168A2 (en) |
JP (1) | JP2008523027A (en) |
KR (1) | KR20070091009A (en) |
CN (1) | CN101072770A (en) |
AR (1) | AR052146A1 (en) |
AU (1) | AU2005313387A1 (en) |
BR (1) | BRPI0518465A2 (en) |
CA (1) | CA2587936A1 (en) |
MX (1) | MX2007006757A (en) |
RU (1) | RU2007125692A (en) |
SA (1) | SA05260388B1 (en) |
TW (1) | TW200626575A (en) |
WO (1) | WO2006061373A2 (en) |
ZA (1) | ZA200704155B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100311969A1 (en) * | 2008-02-05 | 2010-12-09 | Watson Pharma Private Limited | Process For Preparation of Paliperidone |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378255A2 (en) * | 1989-01-09 | 1990-07-18 | Janssen Pharmaceutica N.V. | 2-Aminopyrimidinone derivatives |
WO2000069424A2 (en) * | 1999-05-12 | 2000-11-23 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
WO2004020437A1 (en) * | 2002-08-29 | 2004-03-11 | H. Lundbeck A/S | S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
-
2005
- 2005-12-06 RU RU2007125692/04A patent/RU2007125692A/en not_active Application Discontinuation
- 2005-12-06 TW TW094142934A patent/TW200626575A/en unknown
- 2005-12-06 EP EP05817509A patent/EP1828168A2/en not_active Withdrawn
- 2005-12-06 JP JP2007544893A patent/JP2008523027A/en not_active Withdrawn
- 2005-12-06 KR KR1020077015615A patent/KR20070091009A/en not_active Application Discontinuation
- 2005-12-06 SA SA5260388A patent/SA05260388B1/en unknown
- 2005-12-06 CN CNA2005800419599A patent/CN101072770A/en active Pending
- 2005-12-06 MX MX2007006757A patent/MX2007006757A/en active IP Right Grant
- 2005-12-06 AU AU2005313387A patent/AU2005313387A1/en not_active Abandoned
- 2005-12-06 AR ARP050105089A patent/AR052146A1/en not_active Application Discontinuation
- 2005-12-06 BR BRPI0518465-7A patent/BRPI0518465A2/en not_active IP Right Cessation
- 2005-12-06 WO PCT/EP2005/056501 patent/WO2006061373A2/en active Application Filing
- 2005-12-06 CA CA002587936A patent/CA2587936A1/en not_active Abandoned
-
2007
- 2007-05-22 ZA ZA200704155A patent/ZA200704155B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378255A2 (en) * | 1989-01-09 | 1990-07-18 | Janssen Pharmaceutica N.V. | 2-Aminopyrimidinone derivatives |
WO2000069424A2 (en) * | 1999-05-12 | 2000-11-23 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
WO2004020437A1 (en) * | 2002-08-29 | 2004-03-11 | H. Lundbeck A/S | S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
Non-Patent Citations (2)
Title |
---|
TIMMS G H ET AL: "SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 14, no. 10, 17 May 2004 (2004-05-17), pages 2469-2472, XP004841222 ISSN: 0960-894X * |
VAN HES ROLF ET AL: "SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition." BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 3, 10 February 2003 (2003-02-10), pages 405-408, XP002331578 ISSN: 0960-894X * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100311969A1 (en) * | 2008-02-05 | 2010-12-09 | Watson Pharma Private Limited | Process For Preparation of Paliperidone |
Also Published As
Publication number | Publication date |
---|---|
CA2587936A1 (en) | 2006-06-15 |
AU2005313387A1 (en) | 2006-06-15 |
RU2007125692A (en) | 2009-01-20 |
BRPI0518465A2 (en) | 2008-11-18 |
JP2008523027A (en) | 2008-07-03 |
TW200626575A (en) | 2006-08-01 |
KR20070091009A (en) | 2007-09-06 |
SA05260388B1 (en) | 2009-06-09 |
CN101072770A (en) | 2007-11-14 |
MX2007006757A (en) | 2007-11-09 |
ZA200704155B (en) | 2008-08-27 |
WO2006061373A3 (en) | 2006-09-21 |
AR052146A1 (en) | 2007-03-07 |
EP1828168A2 (en) | 2007-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005313312A1 (en) | Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition | |
NZ539390A (en) | Azaindole derivatives as inhibitors of p38 kinase | |
IL109234A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
KR20080094962A (en) | Amide derivative or salt thereof | |
SK282116B6 (en) | Imidazopyridine derivative, its preparation method, use and pharmaceutical preparation containing it | |
JPH06145170A (en) | Heterocyclic compound, its preparation and medicinal composition for treatment of hypertension and congestive heart failure | |
ZA200704156B (en) | Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
CA2093433C (en) | Sertindole prodrugs | |
JP2006523626A (en) | Pyrazole compounds | |
WO2006061372A2 (en) | Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites | |
JPH05221989A (en) | Heterocyclic compound | |
IL142589A (en) | 3-tetrahydropyridin- 4-yl indoles and pharmaceutical compositions comprising them | |
WO2006061373A2 (en) | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites | |
US7371769B2 (en) | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
US20060122175A1 (en) | Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
PL185141B1 (en) | Novel derivatives of piperidinyl methyloxazolydinone-2, method of obtaining them as well as pharmaceutic preparation and method of obtaining same | |
US20060122177A1 (en) | Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
US20060247256A1 (en) | Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition | |
MX2007006818A (en) | Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 183202 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2587936 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12007501072 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005817509 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/006757 Country of ref document: MX Ref document number: 2415/CHENP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005313387 Country of ref document: AU Ref document number: 2007544893 Country of ref document: JP Ref document number: 200580041959.9 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005313387 Country of ref document: AU Date of ref document: 20051206 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005313387 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077015615 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007125692 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005817509 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0518465 Country of ref document: BR |